OC cell lines (A2780, OVCAR3, CAOV3 and SKOV3) and ovarian epithelial cell line (IOSE80) were purchased from Cell Bank, Chinese Academy of Sciences, Shanghai, China. Cells were cultivated in RPMI-1640 containing 10% FBS (Gibco, USA) at 37 °C, 5% CO2.

Three lines of LINC00665 shRNAs and the negative control were produced by GenePharma, Shanghai, China. MiRNA-34a-5p mimics, inhibitor and negative control were provided by RiboBiotech, Guangzhou, China. Using Lipofectamine 2000 (Invitrogen, USA), plasmids were transfected into cells.

Note: The content above has been extracted from a research article, so it may not display correctly.



Q&A
Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.



We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.